OBI Pharma Inc (台灣浩鼎) yesterday said it is to give an oral presentation about its new breast cancer vaccine, OBI-822, at the annual meeting of the American Society of Clinical Oncology (ASCO) in June.
The company, which received a notice from ASCO late on Wednesday, said ASCO is among the world’s largest and most influential professional organizations representing physicians of all oncology specialties providing care for cancer patients.
With more than 40,000 members, the organization reviews about 5,800 submissions each year, and OBI Pharma’s OBI-822 is among only 3.8 percent of submissions that have been selected for an oral presentation this year, the company said.
However, OBI Pharma chairman Michael Chang (張念慈) said that ASCO’s selection has little commercial implication for the company’s new treatment.
“ASCO’s selection is by no means an endorsement for the new drug, and will not affect the progress of ongoing clinical trials and regulatory approval, apart from a much-needed boost to morale among our employees,” Chang said at a press conference.
OBI Pharma has been embroiled in controversy since Feb. 21, when it announced that the results of its second and third-phase clinical trials of OBI-822 showed “no statistical significance.”
Since then, OBI Pharma shares have plummeted by nearly 40 percent from this year’s high of NT$719 on Feb. 19 to NT$351 at the end of Wednesday’s session.
The shares were suspended for trading on the Taipei Exchange to conform with regulatory guidelines at a time of disclosing material information.
Academia Sinica President Wong Chi-huey (翁啟惠), a close collaborator with the company, has also come under fire since it was revealed that his daughter, Wong Yu-shioh (翁郁秀), had sold a portion of her holdings in OBI Pharma on Feb. 18, just before prices went spiraling downward.
The Chinese-language Apple Daily yesterday reported that Wong Chi-huey had authorized the stock sale with his daughter’s stock broker at E.Sun Securities Co (玉山證券).
Regarding the allegations, Chang said that the company employs industry-standard protocols, where clinical trial information is handled and compartmentalized by external organizations.
“There were no instances of information leakage, and the allegations of insider trading using non-public information are unfounded,” Chang said, adding that Wong Chi-huey did not know of the discouraging clinical trial results until about two hours before the company held a press conference on Feb. 21.
However, Chang was unable to explain how Wong Chi-huey was able to authorize the stock sale on behalf of his daughter.
Wong Chi-huey had previously pledged that he did not hold any biotechnology stock positions.
“The company had instructed board members, managers and employees to halt all stock trades for one month prior to Feb. 21, but we had failed to include Wong Chi-huey and the company regrets the oversight,” Chang said.
Taiwan is projected to lose a working-age population of about 6.67 million people in two waves of retirement in the coming years, as the nation confronts accelerating demographic decline and a shortage of younger workers to take their place, the Ministry of the Interior said. Taiwan experienced its largest baby boom between 1958 and 1966, when the population grew by 3.78 million, followed by a second surge of 2.89 million between 1976 and 1982, ministry data showed. In 2023, the first of those baby boom generations — those born in the late 1950s and early 1960s — began to enter retirement, triggering
One of two tropical depressions that formed off Taiwan yesterday morning could turn into a moderate typhoon by the weekend, the Central Weather Administration (CWA) said yesterday. Tropical Depression No. 21 formed at 8am about 1,850km off the southeast coast, CWA forecaster Lee Meng-hsuan (李孟軒) said. The weather system is expected to move northwest as it builds momentum, possibly intensifying this weekend into a typhoon, which would be called Mitag, Lee said. The radius of the storm is expected to reach almost 200km, she said. It is forecast to approach the southeast of Taiwan on Monday next week and pass through the Bashi Channel
NO CHANGE: The TRA makes clear that the US does not consider the status of Taiwan to have been determined by WWII-era documents, a former AIT deputy director said The American Institute in Taiwan’s (AIT) comments that World War-II era documents do not determine Taiwan’s political status accurately conveyed the US’ stance, the US Department of State said. An AIT spokesperson on Saturday said that a Chinese official mischaracterized World War II-era documents as stating that Taiwan was ceded to the China. The remarks from the US’ de facto embassy in Taiwan drew criticism from the Ma Ying-jeou Foundation, whose director said the comments put Taiwan in danger. The Chinese-language United Daily News yesterday reported that a US State Department spokesperson confirmed the AIT’s position. They added that the US would continue to
The number of Chinese spouses applying for dependent residency as well as long-term residency in Taiwan has decreased, the Mainland Affairs Council said yesterday, adding that the reduction of Chinese spouses staying or living in Taiwan is only one facet reflecting the general decrease in the number of people willing to get married in Taiwan. The number of Chinese spouses applying for dependent residency last year was 7,123, down by 2,931, or 29.15 percent, from the previous year. The same census showed that the number of Chinese spouses applying for long-term residency and receiving approval last year stood at 2,973, down 1,520,
RSS